Expanded Portfolio for Biomolecules Purification Announced

Chromatography

Expanded Portfolio for Biomolecules Purification Announced

12 Oct, 2017

Published over 9 years ago. See the latest and most current information on Chromatography.

With the increased interest in the purification of a wider variety of biomolecules, the portfolio of Kromasil 300 Å has been expanded to support these applications.

The Kromasil 300 Å line of HPLC products is now shipping with C18, C8, C4 and diC4 derivatisations for scientists and engineers exploiting selectivity and loadability for purification of API and impurity isolation. In particular, the new Kromasil 300 Å diC4 has different characteristic than a classic C4, enabling new opportunities to remove impurities from peptide and protein crudes.

For more information, visit www.kromasil.com

Latest News

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Meeting to explore the challenges of measuring ammonia across energy, healthcare and the environment
Explore more Arrow
Pollution Solutions Online
Vacuum technology enables efficient lithium-ion battery recycling with recovery rates of up to 95%
Explore more Arrow
Petro Online
The expanding role of high-temperature, high-shear viscometry in modern engine oil development
Explore more Arrow
Chromatography Today
High-load peptide purification
Explore more Arrow